Point72 Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,340,300
| Closed | -$7.83M | – | 2078 |
|
|
2022
Q4 | $7.83M | Buy |
1,340,300
+1,069,700
| +395% | +$6.25M | 0.03% | 556 |
|
|
2022
Q3 | $1.81M | Buy |
+270,600
| New | +$1.81M | 0.01% | 776 |
|
|
2021
Q1 | – | Sell |
-893,741
| Closed | -$11.3M | – | 1195 |
|
|
2020
Q4 | $11.3M | Buy |
893,741
+118,741
| +15% | +$1.5M | 0.06% | 393 |
|
|
2020
Q3 | $7.61M | Buy |
775,000
+590,862
| +321% | +$5.8M | 0.04% | 439 |
|
|
2020
Q2 | $1.83M | Buy |
+184,138
| New | +$1.83M | 0.01% | 572 |
|
|
2017
Q4 | – | Sell |
-57,134
| Closed | -$843K | – | 981 |
|
|
2017
Q3 | $843K | Buy |
+57,134
| New | +$843K | ﹤0.01% | 639 |
|
|
2016
Q4 | – | Sell |
-414,479
| Closed | -$4.19M | – | 820 |
|
|
2016
Q3 | $4.19M | Buy |
414,479
+10,000
| +2% | +$101K | 0.03% | 419 |
|
|
2016
Q2 | $4.54M | Buy |
404,479
+54,107
| +15% | +$608K | 0.03% | 407 |
|
|
2016
Q1 | $4.79M | Buy |
+350,372
| New | +$4.79M | 0.04% | 396 |
|
|
2015
Q3 | – | Sell |
-555,000
| Closed | -$8.26M | – | 865 |
|
|
2015
Q2 | $8.26M | Buy |
555,000
+29,800
| +6% | +$444K | 0.06% | 332 |
|
|
2015
Q1 | $7.95M | Buy |
525,200
+25,200
| +5% | +$382K | 0.05% | 340 |
|
|
2014
Q4 | $6.66M | Sell |
500,000
-34,200
| -6% | -$456K | 0.05% | 367 |
|
|
2014
Q3 | $6.74M | Buy |
+534,200
| New | +$6.74M | 0.05% | 323 |
|